Vidipha Central Pharmaceutical JSC (HOSE:VDP)

Market Cap	1.04T
Revenue (ttm)	1.02T
Net Income (ttm)	80.22B
Shares Out	22.08M
EPS (ttm)	3,971.57
PE Ratio	11.83
Forward PE	n/a
Dividend	1,500.00 (3.19%)
Ex-Dividend Date	Mar 19, 2025

Volume	4,300
Average Volume	8,602
Open	45,200
Previous Close	46,950
Day's Range	45,200 - 47,000
52-Week Range	33,000 - 58,000
Beta	0.24
RSI	44.51
Earnings Date	Mar 26, 2026

About HOSE:VDP

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products under the Vidipha brand. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamin, minerals, antiseptics, and others. The company also engages in hotel and real estate business; and provision of drug storage and testing, and technology transfer consulting servi...

• Industry: Pharmaceutical Preparations
• Founded: 2003
• Employees: 195
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: VDP

Financial Performance

In 2023, HOSE:VDP's revenue was 1.02 trillion, an increase of 1.14% compared to the previous year's 1.01 trillion. Earnings were 80.22 billion, an increase of 9.07%.